14-day Premium Trial Subscription Try For FreeTry Free
$8.75
+0.495 (+6.00%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 08, 2024 Buy 3 086 Wills Robert James Common Stock
Mar 28, 2024 Buy 6 914 Wills Robert James Common Stock
Feb 23, 2024 Buy 266 Hale David F Common Stock
Feb 23, 2024 Buy 714 Hale David F Common Stock
Feb 23, 2024 Sell 980 Wills Robert James Common Stock
Feb 14, 2024 Buy 28 400 Breitmeyer James B Stock Option
Feb 14, 2024 Buy 6 200 Breitmeyer James B Stock Option
Feb 14, 2024 Buy 14 200 Leavitt Chase C. Stock Option
Feb 14, 2024 Buy 17 700 Krishnan Rajesh Stock Option
Feb 14, 2024 Buy 14 200 Yazji Salim Stock Option
Feb 14, 2024 Buy 14 200 Vincent Richard G Stock Option
Jan 03, 2024 Sell 11 838 Krishnan Rajesh Common Stock
Jan 03, 2024 Sell 19 742 Yazji Salim Common Stock
Jan 03, 2024 Sell 8 868 Vincent Richard G Common Stock
Jan 03, 2024 Sell 11 838 Leavitt Chase C. Common Stock
Jan 03, 2024 Sell 50 955 Breitmeyer James B Common Stock
Jan 03, 2024 Sell 4 485 Breitmeyer James B Common Stock
Oct 02, 2023 Buy 235 000 Leavitt Chase C. Stock Option
Oct 02, 2023 Buy 210 000 Leavitt Chase C. Stock Option
Oct 02, 2023 Buy 65 000 Leavitt Chase C. Stock Option
Oct 02, 2023 Buy 55 519 Leavitt Chase C. Stock Option
Oct 02, 2023 Buy 28 750 Leavitt Chase C. Stock Option
Oct 02, 2023 Sell 65 000 Leavitt Chase C. Stock Option
Oct 02, 2023 Sell 55 519 Leavitt Chase C. Stock Option
Oct 02, 2023 Sell 28 750 Leavitt Chase C. Stock Option
Oct 02, 2023 Sell 210 000 Leavitt Chase C. Stock Option
Oct 02, 2023 Buy 354 400 Yazji Salim Stock Option
Oct 02, 2023 Buy 210 000 Yazji Salim Stock Option
Oct 02, 2023 Buy 92 075 Yazji Salim Stock Option
Oct 02, 2023 Buy 70 600 Yazji Salim Stock Option
Oct 02, 2023 Buy 55 000 Yazji Salim Stock Option
Oct 02, 2023 Sell 210 000 Yazji Salim Stock Option
Oct 02, 2023 Sell 55 000 Yazji Salim Stock Option
Oct 02, 2023 Sell 92 075 Yazji Salim Stock Option
Oct 02, 2023 Sell 354 400 Yazji Salim Stock Option
Oct 02, 2023 Buy 750 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 650 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 637 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 165 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 123 750 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 100 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 66 890 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 65 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 12 500 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 22 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 7 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 2 000 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 100 000 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 66 890 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 750 000 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 165 000 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 12 500 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 65 000 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 22 000 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 7 000 Breitmeyer James B Stock Option
Oct 02, 2023 Sell 2 000 Breitmeyer James B Stock Option
Oct 02, 2023 Buy 280 000 Vincent Richard G Stock Option
Oct 02, 2023 Buy 210 000 Vincent Richard G Stock Option
Oct 02, 2023 Buy 109 597 Vincent Richard G Stock Option
Oct 02, 2023 Buy 75 000 Vincent Richard G Stock Option
Oct 02, 2023 Buy 35 120 Vincent Richard G Stock Option
Oct 02, 2023 Buy 28 750 Vincent Richard G Stock Option
Oct 02, 2023 Sell 75 000 Vincent Richard G Stock Option
Oct 02, 2023 Sell 109 579 Vincent Richard G Stock Option
Oct 02, 2023 Sell 280 000 Vincent Richard G Stock Option
Oct 02, 2023 Sell 28 750 Vincent Richard G Stock Option
Oct 02, 2023 Sell 35 120 Vincent Richard G Stock Option
Oct 02, 2023 Sell 210 000 Vincent Richard G Stock Option
Oct 02, 2023 Buy 220 000 Krishnan Rajesh Stock Option
Oct 02, 2023 Buy 177 050 Krishnan Rajesh Stock Option
Oct 02, 2023 Buy 160 000 Krishnan Rajesh Stock Option
Oct 02, 2023 Buy 75 000 Krishnan Rajesh Stock Option
Oct 02, 2023 Buy 40 000 Krishnan Rajesh Stock Option
Oct 02, 2023 Buy 28 750 Krishnan Rajesh Stock Option
Oct 02, 2023 Buy 12 470 Krishnan Rajesh Stock Option
Oct 02, 2023 Sell 75 000 Krishnan Rajesh Stock Option
Oct 02, 2023 Sell 40 000 Krishnan Rajesh Stock Option
Oct 02, 2023 Sell 12 470 Krishnan Rajesh Stock Option
Oct 02, 2023 Sell 160 000 Krishnan Rajesh Stock Option
Oct 02, 2023 Sell 177 050 Krishnan Rajesh Stock Option
Oct 02, 2023 Sell 28 750 Krishnan Rajesh Stock Option
Oct 02, 2023 Sell 220 000 Krishnan Rajesh Stock Option
Jul 03, 2023 Sell 47 992 Breitmeyer James B Common Stock
Jul 03, 2023 Sell 4 007 Breitmeyer James B Common Stock
Jul 03, 2023 Sell 10 305 Leavitt Chase C. Common Stock
Jul 03, 2023 Sell 7 069 Vincent Richard G Common Stock
Jul 03, 2023 Sell 16 299 Yazji Salim Common Stock
Jul 03, 2023 Sell 10 897 Krishnan Rajesh Common Stock
Jun 28, 2023 Buy 25 000 Theuer Charles Stock Options
Jun 28, 2023 Buy 25 000 Carter Michael G Stock Options
Jun 28, 2023 Buy 25 000 Larue William R Stock Options
Jun 28, 2023 Buy 25 000 Wills Robert James Stock Options
Jun 28, 2023 Buy 25 000 Mazanet Rosemary Stock Options
Jun 28, 2023 Buy 25 000 Nakanishi Xin Stock Options
Jun 28, 2023 Buy 25 000 Kisner Daniel L Stock Options
Jun 28, 2023 Buy 37 500 Hale David F Stock Options
Jun 28, 2023 Buy 25 000 Desimone Jill Stock Options
Jun 14, 2023 Buy 3 000 Kaufmann Gunnar F. Common Stock
Jun 12, 2023 Buy 25 000 Kaufmann Gunnar F. Common Stock
Apr 14, 2023 Buy 2 250 Breitmeyer James B Common Stock
JSON CSV
INSIDER POWER
18.529
Last 100 transactions
Buy: 5 802 851 | Sell: 3 918 128 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 18.529.

In total, the insiders bought 5 802 851 and sold 3 918 128 ONCT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Oncternal Therapeutics, Inc.

Oncternal Therapeutics. Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is al... ONCT Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT